tiprankstipranks
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
RNAC
Cartesian Therapeutics
RESEARCH TOOLSreports
Want to see RNAC full AI Analyst Report?

Cartesian Therapeutics (RNAC) Revenue

1,206 Followers
StatisticsMarket CapRevenue

Cartesian Therapeutics Revenue

Cartesian Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2026, with -100.00%. This bring the company's revenue in the last twelve months to 1.48M, Increased -16.79%. In the fiscal year ending Dec 31, 2025, Cartesian Therapeutics had annual revenue of 2.80M with -92.81% growth.
Revenue (ttm)
1.48M
Revenue Growth
―
P/S Ratio
96.81
Revenue/Employee
$37,293
Employees
75
Market Cap
$270.79M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
2.80M-36.12M-92.81%
Dec 31, 2024
38.91M12.91M+49.64%
Dec 31, 2023
26.00M-84.77M-76.53%
Dec 31, 2022
110.78M25.70M+30.21%
Dec 31, 2021
85.08M68.48M+412.60%
Dec 31, 2020
16.60M9.92M+148.57%
Dec 31, 2019
6.68M5.77M+639.42%
Dec 31, 2018
903.00K696.00K+336.23%
Dec 31, 2017
207.00K――